How reliant is the Indian pharma industry on China?
Finshots Daily
00:00
What India must do to reduce vulnerability
The host asks what India can do and lists realistic goals: secure low-cost generics, multi-year purchase deals, prioritize high-risk APIs and enforce quality.
Play episode from 06:51
Transcript
